Amneal Pharmaceuticals Ownership | Who Owns Amneal Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Amneal Pharmaceuticals Ownership Summary

Amneal Pharmaceuticals is owned by 50.58% institutional investors, 44.12% insiders, and 5.30% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.82% of AMRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 3.24% of its assets in Amneal Pharmaceuticals shares.

AMRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Amneal Pharmaceuticals	50.58%	44.12%	5.30%
Sector	Healthcare Stocks	35.49%	11.78%	52.72%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.39%	13.84%	65.77%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	24.52M	7.82%	$304.77M
Vanguard group	17.91M	5.70%	$225.64M
Tpg gp a	12.33M	3.93%	$153.25M
Blackrock	11.28M	3.67%	$71.64M
Rubric capital management lp	11.04M	3.52%	$137.20M
State street	6.79M	2.17%	$84.46M
Dimensional fund advisors lp	5.69M	1.82%	$70.72M
Morgan stanley	4.64M	1.48%	$57.64M
Geode capital management	4.55M	1.45%	$56.52M
Neuberger berman group	3.68M	1.18%	$45.70M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tpg gp a	12.33M	4.17%	$153.25M
Tucker asset management	1.01M	3.71%	$12.74M
Quartz partners	447.20K	2.15%	$5.56M
Phocas financial	1.00M	1.96%	$12.46M
Blackbarn capital partners lp	1.65M	1.65%	$20.51M
Rubric capital management lp	11.04M	1.45%	$137.20M
Nantahala capital management	2.84M	1.30%	$35.35M
Penn capital management company	1.20M	1.15%	$14.90M
Pfm health sciences, lp	930.10K	1.05%	$11.56M
Freemont management	320.00K	0.60%	$3.98M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	24.52M	0.01%	10.22M
State street	6.79M	0.00%	2.68M
Blackrock	11.28M	0.00%	2.12M
Invesco	3.19M	0.01%	1.44M
Vanguard fiduciary trust	1.15M	0.00%	1.15M

Top Sellers

Holder	Shares	% Assets	Change
Citadel advisors	577.42K	0.00%	-5.60M
Millennium management	369.73K	0.00%	-2.99M
Fosun	-	-	-1.72M
Woodline partners lp	-	-	-1.50M
Hennessy advisors	-	-	-1.50M

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	1.15M	0.00%	1.15M	$14.34M
Norges bank	889.50K	0.00%	889.50K	$11.21M
Public sector pension investment board	607.34K	0.02%	607.34K	$7.55M
Quartz partners	447.20K	2.15%	447.20K	$5.56M
Freemont management	320.00K	0.60%	320.00K	$3.98M

Sold Out

Holder	Change
Clearstead advisors	-1.00
Newedge advisors	-5.00
Global financial private client	-12.00
Wealthspire advisors	-24.00
Flagship harbor advisors	-25.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	314	12.14%	158,512,739	2.52%	50	2.09%	195	26.62%	77	-7.23%
Dec 31, 2025	209	-16.40%	121,259,006	-19.77%	38	1.66%	107	-19.55%	65	-13.33%
Sep 30, 2025	243	1.25%	148,491,323	4.94%	47	2.33%	131	-5.76%	73	25.86%
Jun 30, 2025	235	-0.42%	141,337,020	5.14%	45	2.41%	138	-2.13%	56	5.66%
Mar 31, 2025	236	18.00%	134,653,260	6.93%	43	2.62%	142	14.52%	53	35.90%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	10.35M	3.24%	2.36K
Vanguard Total Stock Mkt Idx Inv	5.51M	1.73%	54.55K
Vanguard US Total Market Shares ETF	4.36M	1.39%	-
Vanguard Small Cap Index	3.99M	1.25%	70.29K
iShares Russell 2000 ETF	3.55M	1.11%	29.94K
Vanguard Small Cap Value Index Inv	2.54M	0.80%	18.10K
Vanguard Institutional Extnd Mkt Idx Tr	1.89M	0.59%	46.34K
State Street SPDR Port S&P 600 Sm CpETF	1.55M	0.49%	540.00
Hennessy Cornerstone Growth Investor	1.50M	0.48%	-171.20K
Invesco S&P SmallCap Momentum ETF	1.47M	0.46%	13.43K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 11, 2026	Autor Deborah M.	-	Sell	$450.56K
Nov 17, 2025	Nark Ted C	-	Sell	$586.00K
Nov 12, 2025	Shah Nikita	Executive Vice President	Sell	$1.57M
Aug 27, 2025	Kiely John	-	Sell	$295.36K
Aug 22, 2025	Shah Nikita	Executive Vice President	Sell	$1.11M

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	1
2026 Q1	-	-
2025 Q4	-	2
2025 Q3	-	11
2025 Q2	-	7

AMRX Ownership FAQ

Who Owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals shareholders are primarily institutional investors at 50.58%, followed by 44.12% insiders and 5.30% retail investors. The average institutional ownership in Amneal Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.39%, which Amneal Pharmaceuticals exceeds.

Who owns the most shares of Amneal Pharmaceuticals?

Amneal Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (24.52M shares, 7.82%), Vanguard group (17.91M shares, 5.70%), and Tpg gp a (12.33M shares, 3.93%). Together, they hold 17.46% of Amneal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amneal Pharmaceuticals?

Yes, BlackRock owns 3.67% of Amneal Pharmaceuticals, totaling 11.28M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 71.64M$. In the last quarter, BlackRock increased its holdings by 2.12M shares, a 23.11% change.

Who is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tpg gp a is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.17% of its assets in 12.33M Amneal Pharmaceuticals shares, valued at 153.25M$.

Who is the top mutual fund holder of Amneal Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amneal Pharmaceuticals shares, with 3.24% of its total shares outstanding invested in 10.35M Amneal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools